IDEXX Laboratories, Inc. (IDXX)

IDXX stock forecast: buy or sell

IDXX stock outlook

  • IDEXX Laboratories stock only changed -0.86% to close at $338.25 on the stock market yesterday.
No ad for you

Please read:
The opinions expressed in this article are personal and should not be followed as recommendations for you to buy or sell shares. The author of this paper does not know the individual positions of the reader, his or her own financial statements or what is in his or her best interest at any given time. All users should speak with their financial advisor before buying or selling any securities Comments are provided for education motives only

IDXX stock chart overview

Should I buy IDEXX Laboratories stock?

All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is IDXX stock a buy?

Currently, IDEXX Laboratories stock matches one trading strategy:

Uptrend buy setup

IDEXX Laboratories stock continues to trend higher since in late March and has marked a gorgeous 100.56% gain. Price marked a local bottom in this uptrend at $294.17 on June 15, and since then it bounced up a 14.98%. Price just broke out above the entry point at $324.30, but it can be traded. If price goes beyond $340.52, you should not chase the price and wait for another opportunity. If you decide to enter this trade, the suggested stop loss is at $291.87

Buy setupBuy pointStop lossRisk
Uptrend buy setup$324.30$291.8710%
No ad for you

Should I sell IDEXX Laboratories stock?

"To sell or not to sell", if you are holding IDEXX Laboratories stock?. As when we have to buy shares, deciding when is the best time to sell is not a capricious decision, and we must follow our own trading strategy. When selling, as well as buying, detailed setups are very easy to follow and are only applicable for selling shares you already own, not for shorting IDEXX Laboratories stock

A golden rule is that you must never hold an investment that generates losses greater than those expected by the time of the buy. The moment to sell shares always has to be determined by the stop-loss (automatic or manual)

Is it time to sell IDEXX Laboratories stock?

Currently, IDEXX Laboratories stock doesn't match any of our preferred sell setups, so if you hold IDEXX Laboratories shares and your operation is in profit probably is not time to sell now

No ad for you

Analysts' recommendations to buy or sell IDEXX Laboratories stock

Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal

In the previous 30 days we couldn't find any rating for IDEXX Laboratories

No ad for you

Technical analysis

IDEXX Laboratories shares started an uptrend in late March, and grew an amazing 100.56%. Rising tops and bottoms can be seen easily on a chart and how price offered very few entry points on the breakouts. Latest pullback was on June 15, when price bounced at $294.17. IDEXX Laboratories broke out above $324.30 (its last top) on June 25. That breakout was a good entry point

SMAs overview

Moving averages are simple tools for investors to detect stock direction. A moving average is calculated as the simple mean of the previous N periods (usually sessions). Moving averages are usually calculated on different periods depending on the trading timeframe 21, 50, 100 and 200 days are the most usual moving averages

Supports and resistances

Investors use supports and resistances as a way to find price points on a chart that tend to work as obstacles, containing the price of shares to move up or down. Supports are levels where the price may stop as it falls. This means that the price is more likely to "rebound" this level rather than break through it. Nevertheless, if the price breaks down this level, it will probably continue declining until finding another support level. On the other side, resistances are where the price may find resistance as it moves up. Likewise, the price is more likely to "bounce off" at this level, and if it finally breaks this level, the price will rise more easily until it approaches the next resistance

Price is at all-time highs and there are not upper resistances.

The current supports are:

  • S1: $324.30 (-4.12% below)
  • S2: $296.25 (-12.42% below)
  • S3: $294.57 (-12.91% below)
  • Bollinger bands

    The so-called Bollinger bands are a well-known technical strategy designed by John Bollinger. It is composed of three lines that are drawn superimposed on the price evolution chart:

    • The central band is a moving average, usually a simple moving average calculated with 20 periods
    • The upper band is calculated by adding to the value of the simple moving average 2 times the standard deviation of the moving average
    • The lower band is calculated by subtracting from the simple moving average 2 times the standard deviation of the moving average

    The price is moving near to the upper Bollinger band, poiting some level of overbought in recent sessions. This is not a bearish indicator, as price can trade in these levels for many days and weeks

    Relative strength index

    The relative strength index (RSI) is a technical indicator used in the analysis of stock markets. It is intended to plot the current and past strength or weakness of a stock or market based on the closing prices of a recent trading period. Like other oscillation indicators, the RSI fluctuates from 0% to 100%. J. Welles Wilder introduced the relative strength indicator in the late 1970s and since then it has been widely used by traders

    The RSI dropped below the overbought level of 70 in early June after just crossing to the overbough zone for 1 day (weak signal). The RSI reading yesterday was 63.52

    No ad for you

    Earnings and financials

    In late April, IDXX hosted the quarterly financial event and presented the first-quarter report. IDXX beat Wall St estimates and posted a per-share earnings of %s of $1.29, that is a 7.5% surprise compared to the initial forecasts of $1.20. Reported revenues were $626.3 million compared to estimates of $617.4 million.

    Compared to the same quarter last year, EPS was $1.17, so posted EPS is a gain of 10.26%. Looking at turnover, figures rose a 8.73% compared to $576.1M year over year. IDEXX Laboratories made 3 year over year quarterly positive results, rising revenue by 23.07% from $508.9M on 2017-Q2.

    IDXX presents quarterly financial report on late next July. Wall Street estimates a per-share earnings of %s of $1.16, compared to Q1 that was $1.29. If you own or you are thinking of buying IDXX shares, you must be vigilant as earnings reporting day usually has a higher than usual volatility, and price can jump up or down with very low liquidity and not honouring your buy/stop-loss orders. You can find more details about the earnings call and the financial reports on the Investor Relations section of its website: http://www.idexx.com.

    No ad for you